Genetic predisposition of RSV infection-related respiratory morbidity in preterm infants

Simon B Drysdale1, Michael Prendergast, Mireia Alcazar

  • 1Division of Asthma, Allergy and Lung Biology, MRC-Asthma UK Centre in Allergic Mechanisms of Asthma, King's College London, London, UK.

Insights

Premature infants may have a genetic predisposition to respiratory syncytial virus (RSV) lower respiratory tract infections (LRTIs). Certain gene variations are linked to increased RSV LRTIs and long-term respiratory issues in these vulnerable infants.

Area of Science:

  • Genetics
  • Neonatology
  • Pulmonology

Background:

  • Premature infants are susceptible to respiratory syncytial virus (RSV) infections.
  • RSV infection can lead to significant respiratory morbidity in preterm infants.
  • The genetic basis for this susceptibility and subsequent morbidity is not fully understood.

Purpose of the Study:

  • To investigate if genetic factors predispose prematurely born infants to respiratory morbidity from RSV infections.
  • To identify specific genetic variations (SNPs) associated with RSV lower respiratory tract infections (LRTIs) and chronic respiratory outcomes.

Main Methods:

  • Prospective follow-up of 146 infants born before 36 weeks gestation.
  • Collection of nasopharyngeal aspirates during lower respiratory tract infections (LRTI).
  • Genetic testing for 11 single-nucleotide polymorphisms (SNPs) and assessment of respiratory health and lung function.

Main Results:

  • A specific single-nucleotide polymorphism (SNP) in the ADAM33 gene was associated with an increased risk of developing RSV LRTIs.
  • SNPs in IL10, NOS2A, SFTPC, MMP16, and VDR genes were linked to increased chronic respiratory morbidity.
  • Reduced lung function at 1 year was associated with SNPs in MMP16, NOS2A, SFTPC, and VDR in infants with prior RSV LRTIs.

Conclusions:

  • Prematurely born infants may possess a genetic predisposition to RSV LRTIs.
  • This genetic predisposition contributes to subsequent respiratory morbidity, independent of initial lung function.
  • Specific gene variations play a role in both the susceptibility to RSV LRTIs and the development of chronic respiratory issues.
Abstract

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.0K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.7K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.2K